Antagonism of protease-activated receptor 2 protects against experimental colitis. - Lohman RJ; Cotterell AJ; Suen J; Liu L; Do AT; Vesey DA; Fairlie DP (The Journal of pharmacology and experimental therapeutics, 2012)